Activin and Inhibin

AS-85 is a potent ASH1L histone methyltransferase inhibitor ( IC 50 =0.6 µM) with anti-leukemic activity. AS-85 strongly binds to the ASH1L SET domain, with the K d value of 0.78 µM.In VitroAS-85 inhibits the growth of leukemia cells (MV4:11,

AS-99 TFA is a first-in-class, potent and selective ASH1L histone methyltransferase inhibitor ( IC 50 = 0.79 µM, K d = 0.89 µM) with anti-leukemic activity. AS-99 TFA blocks cell proliferation, induces apoptosis and differentiation, downregulates

AS-99 TFA is a first-in-class, potent and selective ASH1L histone methyltransferase inhibitor ( IC 50 = 0.79 µM, K d = 0.89 µM) with anti-leukemic activity. AS-99 TFA blocks cell proliferation, induces apoptosis and differentiation, downregulates

AS2717638 is an oral active and selective lysophosphatidic acid receptor 5 (LPA5) antagonist, with an IC 50 of 38 nM for hLPA5. AS2717638 also significantly improves PGE 2 -, PGF 2α -, and AMPA-induced allodyniaForm:SolidIC50&amp: Target:IC50: 38 nM

AS2717638 is an oral active and selective lysophosphatidic acid receptor 5 (LPA5) antagonist, with an IC 50 of 38 nM for hLPA5. AS2717638 also significantly improves PGE 2 -, PGF 2α -, and AMPA-induced allodyniaForm:SolidIC50&amp: Target:IC50: 38 nM

AS2717638 is an oral active and selective lysophosphatidic acid receptor 5 (LPA5) antagonist, with an IC 50 of 38 nM for hLPA5. AS2717638 also significantly improves PGE 2 -, PGF 2α -, and AMPA-induced allodyniaForm:SolidIC50&amp: Target:IC50: 38 nM

AS2717638 is an oral active and selective lysophosphatidic acid receptor 5 (LPA5) antagonist, with an IC 50 of 38 nM for hLPA5. AS2717638 also significantly improves PGE 2 -, PGF 2α -, and AMPA-induced allodyniaForm:SolidIC50&amp: Target:IC50: 38 nM

AS2717638 is an oral active and selective lysophosphatidic acid receptor 5 (LPA5) antagonist, with an IC 50 of 38 nM for hLPA5. AS2717638 also significantly improves PGE 2 -, PGF 2α -, and AMPA-induced allodyniaIC50&amp: Target:IC50: 38 nM (hLPA5).

Asenapine hydrochloride, an antipsychotic, is a 5-HT (1A, 1B, 2A, 2B, 2C, 5A, 6, 7) and Dopamine (D 2 , D 3 , D 4 ) receptor antagonist with K i values of 0.03-4.0 nM for 5-HT and 1.3, 0.42, 1.1 nM for Dopamine receptor , respectively.In

Asenapine hydrochloride, an antipsychotic, is a 5-HT (1A, 1B, 2A, 2B, 2C, 5A, 6, 7) and Dopamine (D 2 , D 3 , D 4 ) receptor antagonist with K i values of 0.03-4.0 nM for 5-HT and 1.3, 0.42, 1.1 nM for Dopamine receptor , respectively.In

Asenapine hydrochloride, an antipsychotic, is a 5-HT (1A, 1B, 2A, 2B, 2C, 5A, 6, 7) and Dopamine (D 2 , D 3 , D 4 ) receptor antagonist with K i values of 0.03-4.0 nM for 5-HT and 1.3, 0.42, 1.1 nM for Dopamine receptor , respectively.In

Asenapine hydrochloride, an antipsychotic, is a 5-HT (1A, 1B, 2A, 2B, 2C, 5A, 6, 7) and Dopamine (D 2 , D 3 , D 4 ) receptor antagonist with K i values of 0.03-4.0 nM for 5-HT and 1.3, 0.42, 1.1 nM for Dopamine receptor , respectively.In